Download PDF
Thromb Haemost 1960; 4(03): 410-423
DOI: 10.1055/s-0038-1654524
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Platelet Activity and Activation of Blood Clotting by Glass

Preben Ollendorff
1   Biological Institute of the Carlsberg Foundation, Copenhagen, Denmark
› Author Affiliations
Further Information

Publication History

Publication Date:
17 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

Through an investigation of the influence of platelet activity on the initiation of clotting by glass contact the following results were obtained:

1. There was no correlation between platelet count and platelet activity in centrifuged plasma.

2. When platelet-rich plasma was treated by excess of powdered glass the activated “foreign surface factor“ (FSF) in plasma was removed by the glass powder.

3. When glass treated high-spun plasma was stored for 24 hours in siliconized tubes all the activity was lost, whereas in samples of glass treated platelet-rich plasma most of the activity remained.

4. It was possible to produce higher FSF activity when the platelet-poor plasma prior to treatment by glass was either adsorbed by BaSO4 or diluted 1: 10.

5. FSF activity was removed when activated plasma was treated with BaSO4. All the results, as well as many contradictory results obtained by other investigators, can be explained by suggesting the presence of an inhibitor in plasma, which reacts against activation of the precursor of the “foreign surface factor“ (pro-FSF). This inhibitor is neutralized by a platelet factor. The active FSF might be identical with activated PTA.

 

  • References

  • (1) Anstall H. B. New Evidence Regarding the Nature and Activation of Christmas Factor. 7th European Congress of Hematology. London: 1959
    Google Scholar
  • (2) Astrup Tage. Plasma Factors Versus Serum Factors in Blood Coagulation. Conference of the International Nomenclature Committees. Montreux: 1959. In print.
    Google Scholar
  • (3) Astrup Tage, Ollendorff Preben. Observations on the activation of thromboplastin. Scand. J. clin. Lab. Invest.. 1960 In print.
    PubMedGoogle Scholar
  • (4) Bordet Jules, Gengou Octave. Recherches sur la Coagulation du Sang et les Sérums Anticoagulants. Ann. Inst. Pasteur. 15: 129-144 1901;
    PubMedGoogle Scholar
  • (5) Conley C. Lockard, Hartmann Robert C, Lailey John S. Studies on the Initiation of Coagulation by Surface Contact. J. clin. Invest. 28: 775 1949;
    PubMedGoogle Scholar
  • (6) Conley C. Lockard, Hartmann Robert C, Morse William I. The Clotting Behaviour of Human “Platelet-Free“ Plasma: Evidence for the Existence of a “Plasma Thromboplastin“. J. clin. Invest. 28: 340-352 1949;
    CrossrefPubMedGoogle Scholar
  • (7) Egli Jr. H. Blood Clotting Factors. Ed. Deutsch E. 193-194 Pergamon Press; London, New York, Paris, Los Angeles: 1958
    Google Scholar
  • (8) Hardisty R. M, Margolis J. The Role of Hageman Factor in the Initiation of Blood Coagulation. Brit. J. Haemat. 5: 203-211 1959;
    CrossrefPubMedGoogle Scholar
  • (9) Johnston Jr. Charles L, Ferguson John H, O’Hanlon Frieda A. Surface Activation of Plasma Clotting: A Function of Hageman Factor. Proc. Soc. exp. Biol. (N. Y.) 99: 197-201 1958;
    CrossrefPubMedGoogle Scholar
  • (10) Koller F. Der heutige Stand der Gerinnungsforschung. Thromb. Diath. haem. 2: 407-727 1958;
    PubMedGoogle Scholar
  • (11) Lewis Jessica H, Walthers Denny, Didisheim Paul, Marchant William. Application of Continuous Flow Electrophoresis to the Study of the Blood Coagulation Proteins and the Fibrinolytic Enzyme System. J. clin. Invest. 37: 1323-1331 1958;
    CrossrefPubMedGoogle Scholar
  • (12) Margolis J. Glass Surface and Blood Coagulation. Nature 178: 805-806 1956;
    PubMedGoogle Scholar
  • (13) Margolis J. The Kaolin Clotting Time. J. clin. Pathol. 11: 406-409 1958;
    CrossrefPubMedGoogle Scholar
  • (14) Nolf P. Eine neue Theorie der Blutgerinnung. Ergebn. inn. Med. Kinderheilk. 10: 275-341 1913;
    PubMedGoogle Scholar
  • (15) O’Brien J. R. The Platelet-like Activity of Serum. Brit. J. Haemat. 1: 223-228 1955;
    CrossrefPubMedGoogle Scholar
  • (16) O'Brien J. R. The Effect of Heparin on the Early Stages of Blood Coagulation. 7th European Congress of Haematology. London: 1959
    Google Scholar
  • (17) Ollendorff Preben. Improvements in the Thrombin-generation Test. Thromb. Diath. haem. 4: 244-252 1960;
    PubMedGoogle Scholar
  • (18) Ollendorff Preben. Initiation of Clotting in Normal and Hageman Plasma by Glass. Nature 186: 173-174 1960;
    CrossrefPubMedGoogle Scholar
  • (19) Quick Armand J, Epstein Ernst. Thromboplastic Activity in Human Blood. J. appl. Physiol. 4: 840-847 1952;
    CrossrefPubMedGoogle Scholar
  • (20) Ratnoff Oscar D. Mechanism of Blood Coagulation. In: Connective Tissue, Thrombosis and Atherosclerosis. Ed. Page I. 213-222 Academic Press; New York and London: 1959
    Google Scholar
  • (21) Ratnoff Oscar D, Rosenblum Jerome M. The Role of Hageman Factor in the Initiation of Clotting by Glass. J. Lab. clin. Med. 50: 941-942 1957;
    PubMedGoogle Scholar
  • (22) Shafrir Eleazar, de Vries Andre. Studies on the Clot-Promoting Activity of Glass. J. clin. Invest. 35: 1183-1190 1956;
    CrossrefPubMedGoogle Scholar
  • (23) Shanberge J. N, Sarelis A, Regan E. E. Heparin Protamine and Thromboplastin Generation. 7th European Congress of Haematology. London: 1959
    Google Scholar
  • (24) Soulier J.-P, Wartelle O, Ménaché D. Hageman Trait and PTA Deficiency; the Role of Contact of Blood with Glass. Brit. J. Haemat. 5: 121-138 1959;
    CrossrefPubMedGoogle Scholar
  • (25) Waaler Bjarne A. Contact Activation in the Intrinsic Blood Clotting System. Scand. J. clin. Lab. Invest. 11 suppl. 37 1959;
    CrossrefPubMedGoogle Scholar